![](https://investorshub.advfn.com/uicon/604629.png?cb=1503346726)
Tuesday, July 31, 2018 9:45:27 PM
Update Log,
2018-06-23 - Evaluation (needs update soon),
2018-07-29 - 2018 10-K Brief Overview,
2018-07-19 - Presentation at Singular Summer Solstice 2018 Conference,
2018-07-17 - Investment Community Conference Call,
2018-07-22 - Comparison HIV-1 Anti-infective antibodies,
2018-06-30 - Pro 140 Related Publications,
2018-06-26 - Pro 140 Metastatic Cancer Suppression,
2018-06-18 - The return of PRO 140, a CCR5-directed mAb,
2018-06-14 - Pro 140 Covering Scientists,
2018-06-23 - Insider Ownership,
2018-06-22 - PRO 140 SC Combo about to arrive,
2018-02-20 - Pro 140 Phase 2b/3 Pivotal PE Achieved,
2018-04-10 - CEO Letter to Investor
Calendar from July 2018 Presentation, PRs & Notes
- DONE: CD02 Pivotal Phase 3 Endpoint Achieved (ASM Microbe late breaker) (Source: CYDY)
- DONE: FDA meeting until end of June '18 to discus BLA/NDA presenting trial data, determining submission plan (Source: CYDY)
- DONE: Full CD02 Trial Data Disclosure via 7/16 PR.
- DONE: Investor Conference Call 7/17 (Source: CYDY IR)
- DONE: 150pt 24weeks safety data, 89 CD03 pts from 2017-10-17 completed on 2018-04-03 (7/17 CC + Deduction)
- DONE: CD03 Enrollment Completed 303pt, but continuing enrollment. 48 weeks complete 2019-06-18 2Q19-3Q19 (7/17 CC + Deduction)
- 8/30: GvHD 30 day data review of 10 additional pts by iDMC soon (CYDY 7/19 CC)???
- 2H18: Publication Studies – CD02 Combo Primary Endpoint Study (Source: CYDY 7/19 CC)
- 2018: File for HIV Breakthrough Therapy Designation (BTD) (Source: CYDY 7/19 CC)
- 2018: IND Submission for Phase 2 in Colon Cancer & MS (Source: CYDY 7/19 CC)
- 1H19: BLA Submission for CD02 Combo (Source: CYDY 7/19 CC)
Expected Milestones:
- ~$70M financing of next 12 Month for HIV-1 and GvHD ex Cancer: Offering, Partnership, ..
- Final terms of ProstaGene acquisition (All share stake for Pestell, how much?)
- 150 pts safety data for Combo BLA (CYDY 7/17 CC)
- Pestell's Mice Data Pro 140 for Breast Cancer?
- CD03 Mono prelim data 2Q19?
- Combo BLA acceptance 2019
- Mono BLA filing 2019, acceptance 2020?
![](http://finesand.files.wordpress.com/2018/07/s18.png)
Recent CYDY News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 09:15:10 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 06/03/2024 09:10:56 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:17:30 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:16:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:09:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:16:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/22/2024 10:16:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:08 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:00:24 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:31:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/29/2024 10:22:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:40:14 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 10:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 10:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:30 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM